DarioHealth Corp. DRIO
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 21.00M | 21.19M | 22.36M | 24.73M | 27.15M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.00M | 21.19M | 22.36M | 24.73M | 27.15M |
| Cost of Revenue | 8.07M | 8.24M | 8.02M | 7.89M | 8.28M |
| Gross Profit | 12.93M | 12.96M | 14.34M | 16.84M | 18.87M |
| SG&A Expenses | 33.60M | 34.47M | 35.53M | 36.66M | 37.95M |
| Depreciation & Amortization | 717.00K | 972.00K | 1.67M | 2.78M | 3.94M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 52.83M | 55.75M | 59.01M | 63.76M | 68.73M |
| Operating Income | -31.83M | -34.56M | -36.66M | -39.03M | -41.58M |
| Income Before Tax | -35.20M | -40.60M | -41.61M | -42.14M | -44.02M |
| Income Tax Expenses | 468.00K | 140.00K | 105.00K | 177.00K | 164.00K |
| Earnings from Continuing Operations | -35.67 | -40.74 | -41.71 | -42.32 | -44.18 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.67M | -40.74M | -41.71M | -42.32M | -44.18M |
| EBIT | -31.83M | -34.56M | -36.66M | -39.03M | -41.58M |
| EBITDA | -29.72M | -32.15M | -33.52M | -34.29M | -35.26M |
| EPS Basic | -7.09 | -17.67 | -25.34 | -25.79 | -27.74 |
| Normalized Basic EPS | -4.08 | -6.84 | -8.49 | -9.17 | -10.90 |
| EPS Diluted | -7.09 | -17.67 | -25.34 | -25.79 | -27.74 |
| Normalized Diluted EPS | -4.08 | -6.84 | -8.49 | -9.17 | -10.90 |
| Average Basic Shares Outstanding | 26.97M | 20.11M | 15.90M | 11.93M | 10.81M |
| Average Diluted Shares Outstanding | 26.97M | 20.11M | 15.90M | 11.93M | 10.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |